Thailand’s Parliament Approves Bill Banning Commercial surrogacy
By AP,
Associated Press in Bangkok
| 11. 28. 2014
Thailand’s interim parliament has given initial approval to a bill banning commercial surrogacy, the practice of hiring a woman to carry a fetus to term.
Thailand was rocked by several surrogacy scandals earlier this year. One involved an Australian couple who took home a healthy baby girl born from a Thai surrogate mother but left behind her twin brother who had Down’s syndrome. The other case involved a Japanese man who fathered at least 16 babies via Thai surrogates.
National Legislative Assembly member Chet Siratharanon said the bill passed its first reading on Thursday, and a finalised version was expected to be ready for consideration within 30 days. The interim government installed after a military coup in May vowed to outlaw commercial surrogacy and punish offenders with up to 10 years in prison.
Thailand is one of the few countries in Asia where commercial surrogacy is not specifically banned by law. The medical council of Thailand has a regulation stating that doctors risk losing their licence if they perform surrogacy for pay. But that penalty has rarely been enforced and...
Related Articles
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Gabriele Pichlhofer and Tino Plümecke, Guest Contributors
| 03.25.2026
A German translation of this interview will be published in May 2026 in the German GID MAGAZIN, which focuses on the market for reproductive technologies. For more information, visit: Gen-ethisches Netzwerk
Egg donation is currently prohibited in Germany and Switzerland, but both countries have been debating its legalization for years. In Switzerland, a legal framework is currently being developed, with a first draft expected by the end of the year. Yet the debate rarely draws on scientific evidence. Instead...
By Charles Pulliam-Moore, The Verge | 03.21.2026
Like many people, director Valerie Veatch was intrigued when OpenAI first released its Sora text-to-video generative AI model to the public in 2024. Though she didn’t fully understand the technology, she was curious about what it could do, and she...
By Ritsuko Kawai, Wired | 03.14.2026
On March 6, Japan’s Ministry of Health, Labor and Welfare officially granted conditional and time-limited marketing authorization to two regenerative medical products derived from reprogrammed iPS cells, marking exactly 20 years since the creation of mouse iPS cells.These will...